Prevest DenPro board to meet on May 27 for FY26 results

1 min read Updated on 21 May 2026, 10:45 PM

Reviewed by

Suketu GScanX News Team

AI Summary

Prevest DenPro Limited will hold a board meeting on May 27, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The trading window is closed from April 01, 2026, and will open 48 hours post-results declaration.

*this image is generated using AI for illustrative purposes only.

Prevest DenPro Limited has announced that its board of directors will meet on Wednesday, May 27, 2026. The primary agenda of the meeting is to consider and approve the audited standalone and consolidated financial results of the company for the quarter and financial year ended March 31, 2026.

The meeting is being convened in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board will review the company's performance for the full financial year and the final quarter of FY26.

Trading Window Closure

In accordance with the company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the company's securities has been closed since April 01, 2026. This restriction applies to all designated persons of the company.

The window will remain closed and will reopen 48 hours after the audited standalone and consolidated financial results are declared to the stock exchanges. This measure is intended to ensure compliance with regulatory norms regarding insider trading.

Key Meeting Details

Detail	Information
Meeting Date	May 27, 2026
Financial Period	Quarter and year ended March 31, 2026
Agenda	Audited Standalone and Consolidated Financial Results
Trading Window Closed From	April 01, 2026

How does Prevest DenPro's FY26 revenue and profit growth compare to its dental consumables peers listed on Indian exchanges?

Will the board consider announcing a dividend or share buyback alongside the FY26 results given the company's cash position?

How might Prevest DenPro's export performance in FY26 reflect broader trends in India's dental products industry competing in global markets?

Director Cessation Details

Mr. Pardeep Gandotra (DIN: 08733719) ceased to hold office as Independent Director of the company effective from the closure of business hours on April 26, 2026. The cessation occurred due to the natural completion of his tenure as an Independent Director, marking the end of his scheduled term with the company.

Parameter:	Details
Director Name:	Mr. Pardeep Gandotra
DIN:	08733719
Position:	Independent Director
Reason for Change:	Completion of tenure
Effective Date:	April 26, 2026 (closure of business hours)

Regulatory Compliance

The company fulfilled its regulatory obligations by filing the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made in accordance with SEBI Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Managing Director Atul Modi (DIN: 00788272) signed the disclosure document on behalf of Prevest Denpro Limited. The company has also committed to making this information available on its official website for stakeholder reference.

Corporate Governance Impact

The cessation represents a routine board transition as Independent Directors serve fixed terms under corporate governance norms. The completion of Mr. Gandotra's tenure follows the standard practice of Independent Director appointments, which are subject to specific tenure limits as per regulatory requirements.

Who will Prevest Denpro appoint as the new Independent Director to fill the vacancy left by Mr. Gandotra's departure?

How might this board transition impact Prevest Denpro's strategic decision-making and corporate governance practices in the coming quarters?

Will the company face any challenges in maintaining board independence ratios required under SEBI regulations following this cessation?